Poll says majority will not prescribe Avandia
Filed under: Type 2, Childhood, Adult Onset, Drugs, Research, Daily News, Complications
Avandia-maker GlaxoSmithKline might hog breathed a sigh of relief after the U.S. Aliment and Drug Administration's (FDA) panel voted to conserve Avandia on the market. But positiveness me, it is a perfect substantial sigh This referendum was followed by the panel's official acknowledgment (20-3) the narcotic increases risk of heart blitz in patients with type 2 diabetes.
What are the healthcare professionals saying? In a contemporary MedPage Today poll, sole a trickle of respondents (9 percent) stated they would keep up prescribing Avandia with no worries. One in four said the drug should be swept off the shelves. Per the FDA panel's recommendation, 36 percent stated they would endure treating confident patients with Avandia. But a whopping 55 percent will not communicate any extra Avandia prescriptions. MedPage Today pointed gone the current physician strike against Avandia could crumble a bit over time. When a tardy May meta-analysis showed a 43 percent higher risk of heart incursion for Avandia takers, a MedPage Today referendum initiated shortly thereafter revealed 75 percent would not correspond any contemporary prescriptions. Today, this 'no modern prescriptions' number stands at a lower 55 percent.
The sages remark 'time heals all wounds', but Avandia will possible be tattooed with the FDA's strictest black box warning. GlaxoSmithKline can knock on doctor doors and perform a popular relations tap dance, but I vacillate the Shim Sham will ever send this drug to previous sales levels. At the moment, healthcare professionals act not expect so either. They contemplate that tattoo.
Read | Permalink | Email this | Comments: August 26, 2009
